Pluskiewicz W, Drozdzowska B
Department and Clinic of Internal and Allergic Diseases, Zabrze, Poland.
Osteoporos Int. 1998;8(6):578-83. doi: 10.1007/s001980050102.
The aim of this cross-sectional study was to evaluate skeletal status in Polish early postmenopausal women using ultrasound measurement at the proximal phalanges of the hand. We assessed the ability of the method to discriminate between healthy and osteoporotic individuals, the influence of age and menopause on ultrasound values, the impact of hormone replacement therapy and the relationships between ultrasound measurement and type of fracture. Five hundred and three early postmenopausal women were divided into three groups: (1) healthy (n = 398, mean age 53.4 years), (2) fractured (n = 43, mean age 53.9 years), (3) treated with estrogens (n = 62, mean age 53.5 years). Groups were matched for age and years since menopause (YSM). Group 2 was subdivided into those with and without wrist fracture. No drugs except estrogens were used by the subjects studied and no diseases known to affect bone metabolism were observed. Bone status was assessed by a DBM Sonic 1200 (Igea, Italy), a device that measures amplitude-dependent speed of sound (AD-SoS) at the proximal phalanges II-V of the hand. AD-SoS had the highest value in estrogen-treated women (1996.5 +/- 66.5 m/s), the lowest in fractured persons (1883.6 +/- 77.1 m/s) and a medium value in healthy women (1949.2 +/- 78.0 m/s). All values were significantly different from each other (p < 0.0001). AD-SoS values for the subgroups of group 2 were 1873.0 +/- 80.6 m/s for those with wrist fracture and 1914.0 +/- 73.0 m/s for those without; they were not statistically different. The hypothesis that AD-SoS at the proximal phalanges might be more sensitive to wrist fracture was not confirmed by Fisher's exact test for frequencies. Linear regression showed age-related changes, with r values -0.4 (p < 0.00001), -0.47 (p < 0.005), -0.37 (p < 0.005), and YSM-related changes, with r values of -0.44 (p < 0.00001), -0.32 (p < 0.005), and -0.18 (NS) in groups 1, 2 and 3, respectively. It is concluded that: (1) ultrasound measurements of the proximal phalanges were able to discriminate between healthy and osteoporotic individuals; (2) the method is useful in detecting age and postmenopause-related changes within the skeleton; and (3) hormone replacement therapy significantly reduced the impact of the menopause on bone loss as detected by ultrasound.
这项横断面研究的目的是通过对手部近端指骨进行超声测量,评估波兰绝经后早期女性的骨骼状况。我们评估了该方法区分健康个体和骨质疏松个体的能力、年龄和绝经对超声值的影响、激素替代疗法的影响以及超声测量与骨折类型之间的关系。503名绝经后早期女性被分为三组:(1)健康组(n = 398,平均年龄53.4岁),(2)骨折组(n = 43,平均年龄53.9岁),(3)雌激素治疗组(n = 62,平均年龄53.5岁)。各组在年龄和绝经年限(YSM)方面进行了匹配。第2组又细分为有腕部骨折和无腕部骨折的两组。研究对象除雌激素外未使用其他药物,也未观察到已知影响骨代谢的疾病。使用DBM Sonic 1200(意大利伊盖亚公司)评估骨状况,该设备可测量手部近端II - V指骨处的振幅依赖声速(AD - SoS)。AD - SoS在接受雌激素治疗的女性中值最高(1996.5 +/- 66.5米/秒),在骨折患者中值最低(1883.6 +/- 77.1米/秒),在健康女性中值居中(1949.2 +/- 78.0米/秒)。所有值之间均存在显著差异(p < 0.0001)。第2组亚组中,有腕部骨折者的AD - SoS值为1873.0 +/- 80.6米/秒,无腕部骨折者为1914.0 +/- 73.0米/秒;两者无统计学差异。对于频率的Fisher精确检验未证实近端指骨处的AD - SoS对腕部骨折可能更敏感这一假设。线性回归显示,第1、2和3组中,与年龄相关的变化r值分别为 - 0.4(p < 0.00001)、 - 0.47(p < 0.005)、 - 0.37(p < 0.